Persistence of Kaposi sarcoma-associated herpesvirus (KSHV)-infected gels in KSHV/HIV-1-coinfected subjects without KSHV-associated diseases

Journal of Infectious Diseases

Volumn 191, Issue 3, 2005, Pages 367-371

  Campbell, Thomas B ^a   Staskus, Katherine A ^b   Folkvord, Joy ^a   White, Irene E ^a   Meid, James ^a   Zhang, Xing Quan ^a   Connick, Elizabeth ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENCY ASSOCIATED NUCLEAR ANTIGEN; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; KAPOSI SARCOMA; LATENT VIRUS INFECTION; LYMPH FOLLICLE; LYMPH NODE CELL; MALE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SUPERINFECTION; VIRUS EXPRESSION; VIRUS GENE; VIRUS LATENCY;

ADULT; B-LYMPHOCYTES; DISEASE RESERVOIRS; FEMALE; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; SARCOMA, KAPOSI; VIRUS LATENCY;

EID: 12344332500     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/427194     Document Type: Article

References (15)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-9.
2. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332:1186-91.
3. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86:1276-80.
4. Mesri EA, Cesarman E, Arvanitakis L, et al. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996; 183:2385-90.
5. Campbell TB, Fitzpatrick L, MaWhinney S, Zhang XQ, Schooley RT. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection. J Acquir Immune Defic Syndr 1999; 22:333-40.
6. + cells and HIV-1-producing cells in human lymphoid tissue in vivo. J Acquir Immune Defic Syndr 2003; 32:469-76.
7. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348:1133-8.
8. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996; 10:175-80.
9. White IE, Campbell TB. Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR. J Clin Microbiol 2000; 38:1992-5.
10. Staskus KA, Zhong W, Gebhard K, et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997; 71:715-9.
11. Staskus KA, Sun R, Miller G, et al. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 1999; 73:4181-7.
12. Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Nat Acad Sci USA 1999; 96:4546-51.
13. O'Leary JJ, Kennedy M, Luttich K, et al. Localisation of HHV-8 in AIDS related lymphamdenopaty. J Clin Pathol: Mol Pathol 2000; 53: 43-7.
14. Parravicini C, Chandran B, Corbellino M, et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 2000; 156:743-9.
15. Cannon JS, Nicholas J, Orenstein JM, et al. Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. J Infect Dis 1999; 180:824-8.